Infectious Disease
Syphilis Diagnosis & Management
Stage clinically + serologically, benzathine penicillin G, Jarisch-Herxheimer counselling, partner notification, follow-up.
Source: BASHH 2024
Step 1 of ~2
info
Stage by Clinical + Serology
Stages:
• Primary: painless chancre (3–90 days post-exposure).
• Secondary (4–10 weeks post-chancre): rash (palms + soles classical), fever, lymphadenopathy, condyloma lata, mucous patches.
• Latent: asymptomatic, serology positive (early <2 years; late >2 years or unknown).
• Tertiary: gummatous, cardiovascular, neurosyphilis (years-decades).
Serology:
• Treponemal-specific (TP-PA, FTA-ABS, EIA): positive lifelong even after treatment.
• Non-treponemal (RPR, VDRL): titre falls with treatment; useful for monitoring.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Benzathine Benzylpenicillin · Long-Acting Penicillin — Syphilis / Rheumatic Fever Prophylaxis
- Benzathine benzylpenicillin · Long-acting penicillin
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Benzylpenicillin (Penicillin G) · Beta-lactam antibiotic (natural penicillin)
- Doxycycline 100mg Capsules (Sinusitis — Penicillin Allergy) · Tetracycline antibiotic
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023
Decision support only. Always apply local guidelines and clinical judgement.